Capital Square’s Clorox CLX Stock Holding History

Capital Square’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-376	Closed	-$65K	–	165
2020 Q1	$65K	Buy	+376	New	+$62.1K	0.08%	178

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital Square's CLX Position: Q2 2020 in Review

Capital Square sold out of Clorox (CLX) in Q2 2020, closing a stake of 376 shares — an estimated $65K sold.

Capital Square first reported a position in CLX in Q1 2020 and held it in 1 quarter. The position peaked at $65K in Q1 2020. 1,198 funds tracked by Wall St. Rank hold CLX as of Q2 2020.

Capital Square reported no remaining Clorox position as of Q2 2020 after selling out during the quarter.
Capital Square sold 376 Clorox shares in Q2 2020, an estimated $65K.
Capital Square first reported a position in Clorox in Q1 2020 and held it in 1 quarter.
Capital Square's Clorox position peaked at $65K in Q1 2020.
1,198 funds tracked by Wall St. Rank held Clorox as of Q2 2020.

Based on Capital Square's 13F filing for Q2 2020, filed 27 Jul 2020.